Northern Trust Corp Passage Bio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Passage Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 40,281 shares of PASG stock, worth $23,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,281

Previous 64,512 37.56%

Holding current value

$23,765

Previous $50,000 44.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.64 - $1.0 $15,507 - $24,231	-24,231 Reduced 37.56%	40,281 $28,000
Q2 2024 Aug 14, 2024	SELL	$0.79 - $1.58 $15,606 - $31,212	-19,755 Reduced 23.44%	64,512 $50,000
Q1 2024 May 14, 2024	BUY	$0.86 - $1.73 $6,348 - $12,770	7,382 Added 9.6%	84,267 $113,000
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.01 $14,263 - $24,009	23,772 Added 44.76%	76,885 $77,000
Q3 2023 Nov 13, 2023	SELL	$0.66 - $1.01 $3,300 - $5,050	-5,000 Reduced 8.6%	53,113 $35,000
Q2 2023 Aug 11, 2023	SELL	$0.82 - $1.19 $2,286 - $3,318	-2,789 Reduced 4.58%	58,113 $54,000
Q1 2023 May 15, 2023	BUY	$0.96 - $1.88 $1,803 - $3,532	1,879 Added 3.18%	60,902 $58,000
Q4 2022 Feb 13, 2023	SELL	$1.06 - $1.48 $3,158 - $4,410	-2,980 Reduced 4.81%	59,023 $81,000
Q3 2022 Nov 14, 2022	BUY	$1.22 - $2.48 $3,750 - $7,623	3,074 Added 5.22%	62,003 $78,000
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $429,332 - $911,343	-263,394 Reduced 81.72%	58,929 $139,000
Q1 2022 May 13, 2022	SELL	$2.66 - $6.49 $49,316 - $120,324	-18,540 Reduced 5.44%	322,323 $1 Million
Q4 2021 Feb 08, 2022	BUY	$6.24 - $10.2 $80,458 - $131,518	12,894 Added 3.93%	340,863 $2.16 Million
Q3 2021 Nov 15, 2021	SELL	$9.73 - $15.52 $137,300 - $219,002	-14,111 Reduced 4.13%	327,969 $3.27 Million
Q2 2021 Aug 13, 2021	BUY	$12.44 - $19.45 $479,537 - $749,758	38,548 Added 12.7%	342,080 $4.53 Million
Q1 2021 May 12, 2021	BUY	$16.24 - $29.83 $620,725 - $1.14 Million	38,222 Added 14.41%	303,532 $5.31 Million
Q4 2020 Feb 11, 2021	BUY	$14.28 - $29.73 $1.35 Million - $2.81 Million	94,395 Added 55.23%	265,310 $6.78 Million
Q3 2020 Nov 16, 2020	BUY	$12.39 - $26.15 $1.28 Million - $2.69 Million	103,055 Added 151.86%	170,915 $2.24 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $36.07 $990,077 - $2.45 Million	67,860 New	67,860 $1.86 Million

Others Institutions Holding PASG

# of Institutions

Shares Held

38.7M

Call Options Held

7.7K

Put Options Held

View Full List

About Passage BIO, Inc.

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

More about PASG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Passage Bio, Inc. Transaction History